Tamiko Griffin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 332 County Road 1150, Kennard, TX 75847 Phone: 936-215-9004 |
News Archive
Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation.
With a 30 per cent revenue share, Europe trails the United States as the second largest regional market for therapeutic peptides. The rising need for new therapeutic approaches combined with the potential of peptides as active pharmaceutical ingredients for effective drug formulation is contributing to rapid market development.
Imagine needing a critical test at your local hospital, but having to wait days to be tested because there was no laboratory professional available to run the tests. This scene seems unimaginable, but with the federal government estimating that nearly 140,000 new medical lab professionals are needed by 2012 and only 50,000 are expected to be trained on time, this scenario is a reality in some parts of the country. Some states, like California, are taking aggressive action to reverse this trend.
Barr Pharmaceuticals, Inc. today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by AstraZeneca LP in connection with its Entocort(R) Enteric Coated Capsules (budesonide), 3mg.
In a patient study of over 1,000 individuals with coronary artery disease (CAD), researchers have found that high levels of an enzyme called PLTP significantly increased the risk of heart attack in the subset of patients taking statins.
› Verified 2 days ago